NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Red,

Brilliant. It will be interesting to see how the FDA and NWBO proceed with the new and improved DCVax-L and Prostate once the current DCVax-L results are in on phase 3. The new legislation wording regarding stem cell and immunotherapy from Japan may flow into the U.S.. I think the new DCVAX-L and Prostate versions may get orphan and fast track status due to the overall remarkable safety profile of dendritic immunotherapy, the diseases themselves (need for new trx.), and the (hopefully) stunning efficacy results of their predecessors.